Chordate Medical Holding
15,45
SEK
+0,32 %
CMH
First North Stockholm
Biotechnology & Pharmaceuticals
Health Care
1 investor følger denne virksomhed
+0,32%
-35,63%
-34,26%
-40,35%
-74,63%
-83,69%
-95,55%
-92,81%
-99,2%
www.chordate.com/investor-relations
Chordate Medical Holding is a medical technology company that has developed, patented and CE-marked a nerve-modulating treatment technique for chronic migraine and chronic nasal congestion (rhinitis), Kinetic Oscillation Stimulation (KOS). The company sells its products to treating clinics in selected European markets, Israel and Saudi Arabia, with the aim of increasing its presence in the global market.
Omsætning
980 t
EBIT %
-3.017,35 %
P/E
-
Udbytteafkast, %
-
Kursmål
-
Anbefaling
-
Opdateret
-
First North Stockholm
CMH
Daglig lav / høj pris
15,45 / 15,45
SEK
Markedsværdi
17,13 mio. SEK
Aktieomsætning
494,4 SEK
Volumen
32
Finanskalender
Årsrapport
28.02.2025
Generalforsamling
21.05.2025
Delårsrapport
23.05.2025
Større aktionærerKilde: Millistream Market Data AB
| Ejer | Kapital | Stemmer |
|---|---|---|
| Lars Ingvarsson inkl bolag | 12,2 % | 12,2 % |
| Hawoc Investment AB | 9,1 % | 9,1 % |
| Isak Brandberg AB med närstående | 8,2 % | 8,2 % |
| Tommy Hedberg | 7,6 % | 7,6 % |
| Tor-Björn Bengtsson | 4,5 % | 4,5 % |
| Carsten Johansen | 2,5 % | 2,5 % |
| Nordnet Pensionsförsäkring AB | 2,2 % | 2,2 % |
| David Nyman | 2,0 % | 2,0 % |
| Conny Holmström | 1,4 % | 1,4 % |
| Henrik Rammer | 1,4 % | 1,4 % |
ViserAlle indholdstyper
Last day of trading with warrants of series TO 8 in Chordate Medical Holding AB (publ)
Major Shareholders and Management Announce Intent to Exercise TO8 Warrants in Chordate Medical Holding AB (publ.)
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools